These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8105944)

  • 41. Can low-calcium peritoneal dialysis solution safely replace the standard calcium solution in the majority of chronic peritoneal dialysis patients?
    Buijsen CG; Struijk DG; Huijgen HJ; Boeschoten EW; Wilmink JM
    Perit Dial Int; 1996; 16(5):497-504. PubMed ID: 8914179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients.
    van der Sande FM; Cheriex EC; van Kuijk WH; Leunissen KM
    Am J Kidney Dis; 1998 Jul; 32(1):125-31. PubMed ID: 9669433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Total dialysate calcium effects on calcium balance during dialysis.
    Eftimovska-Otovic N; Babalj-Banskolieva E; Bogdanoska-Kostadinoska S; Milovanceva-Popovska M; Grozdanovski R
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):25-30. PubMed ID: 24566012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of low calcium dialysate on left ventricular diastolic function in peritoneal dialysis patients.
    Wang Z; Wen Y; Liang J; Liang X; Shi W
    Ren Fail; 2016 Nov; 38(10):1665-1671. PubMed ID: 27759470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium-free hemodialysis for the management of hypercalcemia.
    Koo WS; Jeon DS; Ahn SJ; Kim YS; Yoon YS; Bang BK
    Nephron; 1996; 72(3):424-8. PubMed ID: 8852491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis.
    Kyriazis J; Stamatiadis D; Mamouna A
    Am J Kidney Dis; 2000 Jun; 35(6):1096-103. PubMed ID: 10845823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Simple treatment of tumor-induced hypercalcemia: i.v. aminohydroxypropylidene biphosphonate].
    Portmann L; Häfliger JM; Bill G; Burckhardt P
    Schweiz Med Wochenschr; 1983 Dec; 113(51):1960-3. PubMed ID: 6318306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment with assisted automated peritoneal dialysis using 4.25% glucose dialysate for an elderly patient with refractory heart failure.
    Toda N; Iwaki R; Oishi K; Takasu Y; Komiya T
    CEN Case Rep; 2021 Feb; 10(1):121-125. PubMed ID: 32930999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature.
    Cardella CJ; Birkin BL; Rapoport A
    Clin Nephrol; 1979 Dec; 12(6):285-90. PubMed ID: 160852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypercalcemia in a peritoneal dialysis patient.
    Prichard S; Fried L
    Perit Dial Int; 2001; 21(4):420-7. PubMed ID: 11587413
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients.
    Demirci MS; Ozkahya M; Asci G; Sevinc E; Yilmaz M; Demirci C; Toz H; Basci A; Ok E
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S15-7. PubMed ID: 19270206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical application of low calcium peritoneal dialysate.
    Kawanishi H; Tsuchiya T; Namba S; Takahashi N; Toyota T; Fukuma K; Kawai T
    ASAIO Trans; 1991; 37(3):M404-6. PubMed ID: 1751210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.
    Frazao J; Coburn JW
    Am J Kidney Dis; 1995 Nov; 26(5):831-5. PubMed ID: 7485141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.
    Hamada C; Hayashi K; Shou I; Inaba M; Ro Y; Io H; Maeda K; Fukui M; Tomino Y
    Perit Dial Int; 2005; 25(6):570-5. PubMed ID: 16411524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate.
    Hou SH; Zhao J; Ellman CF; Hu J; Griffin Z; Spiegel DM; Bourdeau JE
    Am J Kidney Dis; 1991 Aug; 18(2):217-24. PubMed ID: 1867178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
    Dahmani O; Sophoclis C; Kebir M; Bouguern D; Sakho A; Demarchi P
    Saudi J Kidney Dis Transpl; 2017; 28(1):154-157. PubMed ID: 28098117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute effect of a peritoneal dialysis exchange on electrolyte concentration and QT interval in uraemic patients.
    Genovesi S; Nava E; Bartolucci C; Severi S; Vincenti A; Contaldo G; Bigatti G; Ciurlino D; Bertoli SV
    Clin Exp Nephrol; 2019 Nov; 23(11):1315-1322. PubMed ID: 31423549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium profiling in hemodiafiltration: a new way to reduce the calcium overload risk without compromising cardiovascular stability.
    Severi S; Bolasco P; Badiali F; Concas G; Mancini E; Summa A; Perazzini C; Steckiph D; Cagnoli L; Santoro A
    Int J Artif Organs; 2014 Mar; 37(3):206-14. PubMed ID: 24744165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of intraperitoneal calcium therapy in a rodent model.
    Christenson M; Fivush B; Racusen L
    Adv Perit Dial; 1992; 8():15-7. PubMed ID: 1361773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peritoneal dialysis in the treatment of severe hypercalcemia.
    Hamilton JW; Lasrich M; Hirszel P
    J Dial; 1980; 4(2-3):129-38. PubMed ID: 7440844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.